Magenta's R&D head hits the exit just weeks after reading out mid-stage data for lead therapy, eyeing clinic for another
Cambridge, MA-based Magenta Therapeutics has had a mostly quiet few years as it steers its stem cell transplant hopefuls through early-stage human trials. For the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
